Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages 1631-1640

  Hazlehurst, Jonathan M ^a   Gathercole, Laura L ^a   Nasiri, Maryam ^a   Armstrong, Matthew J ^a   Borrows, Sarah ^b   Yu, Jinglei ^a   Wagenmakers, Anton J M ^a   Stewart, Paul M ^a   Tomlinson, Jeremy W ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HYDROCORTISONE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; PALMITIC ACID; PROTEIN KINASE B;

ADIPOCYTE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRS2 GENE; LIPID STORAGE; LIPOLYSIS; LIVER CELL CULTURE; MALE; NORMAL HUMAN; PKB GENE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TISSUE SPECIFICITY; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFUSION PUMPS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PLACEBOS; SUBCUTANEOUS FAT;

EID: 84876263472     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3523     Document Type: Article

References (37)

1. Van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM. 2000; 93(2): 105-111.
2. Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken). 2013; 65(2): 294-298.
3. Morgan SA, Tomlinson JW. 11 β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes. Expert Opin Investig Drugs. 2010; 19(9): 1067-1076.
4. Gathercole LL, Bujalska IJ, Stewart PM, Tomlinson JW. Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue. J Clin EndocrinolMetab. 2007; 92(11): 4332-4339.
5. Gathercole LL, Morgan SA, Bujalska IJ, Hauton D, Stewart PM, Tomlinson JW. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue. PLoS One. 2011; 6(10):e26223.
6. Tomlinson JJ, Boudreau A, Wu D, et al. Insulin sensitization of human preadipocytes through glucocorticoid hormone induction of forkhead transcription factors. Mol Endocrinol. 2010; 24(1): 104-113.
7. Gathercole LL, Morgan SA, Bujalska IJ, Stewart PM, Tomlinson JW. Short-and long-term glucocorticoid treatment enhances insulin signalling in human subcutaneous adipose tissue. Nutr Diabetes. 2011; 1: e3.
8. Hauner H, Schmid P, Pfeiffer EF. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab. 1987; 64(4): 832-835.
9. Morgan SA, Sherlock M, Gathercole LL, et al. 11β-Hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Diabetes. 2009; 58: 2506-2515.
10. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem. 2002; 277(2): 1531-1537.
11. Larsson H, Ahren B. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab. 1996; 81(12): 4428-4432.
12. Zarkovic M, Beleslin B, Ciric J, et al. Glucocorticoid effect on insulin sensitivity: a time frame. JEndocrinol Invest. 2008; 31(3): 238-242.
13. Lonn L, Kvist H, Ernest I, Sjostrom L. Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism. 1994; 43(12): 1517-1522.
14. Rockall AG, Sohaib SA, Evans D, et al. Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome. Eur J Endocrinol. 2003; 149(6): 561-567.
15. Lundgren M, Buren J, Ruge T, Myrnas T, Eriksson JW. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J Clin Endocrinol Metab. 2004; 89(6): 2989-2997.
16. Amatruda JM, Danahy SA, Chang CL. The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes. Biochem J. 1983; 212(1): 135-141.
17. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes. 1987; 36(8): 914-924.
18. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci. 1959; 82: 420-430.
19. Diraison F, Pachiaudi C, Beylot M. In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated. Metabolism. 1996; 45(7): 817-821.
20. Lee WN, Bassilian S, Ajie HO, et al. In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis. Am J Physiol. 1994; 266(5 Pt 1):E699-E708.
21. Diraison F, Pachiaudi C, Beylot M. Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J Mass Spectrom. 1997; 32(1): 81-86.
22. Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, Stewart PM. Weight loss increases 11 β-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. J Clin Endocrinol Metab. 2004; 89(6): 2711-2716.
23. Brennan-Speranza TC, Henneicke H, Gasparini SJ, et al. Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest. 2012; 122(11): 4172-4189.
24. Laskewitz AJ, van Dijk TH, Bloks VW, et al. Chronic prednisolone treatment reduces hepatic insulin sensitivity while perturbing the fed-to-fasting transition in mice. Endocrinology. 2010; 151(5): 2171-2178.
25. Laskewitz AJ, van Dijk TH, Grefhorst A, et al. Chronic prednisolone treatment aggravates hyperglycemia in mice fed a high-fat diet but does not worsen dietary fat-induced insulin resistance. Endocrinology. 2012; 153: 3713-3723.
26. Probst I, Jungermann K. Short-term regulation of glycolysis by insulin and dexamethasone in cultured rat hepatocytes. Eur JBiochem. 1983; 135(1): 151-156.
27. Fleig WE, Nother-Fleig G, Steudter S, Enderle D, Ditschuneit H. Regulation of insulin binding and glycogenesis by insulin and dexamethasone in cultured rat hepatocytes. Biochim Biophys Acta. 1985; 847(3): 352-361.
28. D'Souza AM, Beaudry JL, Szigiato AA, et al. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. Am J Physiol Gastrointest Liver Physiol. 2012; 302(8):G850-G863.
29. Yu CY, Mayba O, Lee JV, et al. Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One. 2010; 5(12): e15188.
30. Elliott P, Peters RF, White AM. A study of the relationship between glucocorticoid-induced weight loss in rats and the activity of skeletal-muscle and cardiac-muscle ribosomes in vitro. Biochem J. 1971; 125(4): 106P-107P.
31. Tonolo G, Fraser R, Connell JM, Kenyon CJ. Chronic low-dose infusions of dexamethasone in rats: effects on blood pressure, body weight and plasma atrial natriuretic peptide. J Hypertens. 1988; 6(1): 25-31.
32. Slavin BG, Ong JM, Kern PA. Hormonal regulation of hormonesensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res. 1994; 35(9): 1535-1541.
33. Serr J, Suh Y, Oh SA, Shin S, Kim M, Latshaw JD, Lee K. Acute up-regulation of adipose triglyceride lipase and release of non-esterified fatty acids by dexamethasone in chicken adipose tissue. Lipids. 2011; 46(9): 813-820.
34. van Raalte DH, Brands M, van der Zijl NJ, et al. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia. 2011; 54(8): 2103-2112.
35. Kauh EA, Mixson LA, Shankar S, et al. Short-term metabolic effects of prednisone administration in healthy subjects. Diabetes Obes Metab. 2011; 13(11): 1001-1007.
36. Samra JS, Clark ML, Humphreys SM, MacDonald IA, Bannister PA, Frayn KN. Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab. 1998; 83(2): 626-631.
37. Rockall AG, Sohaib SA, Evans D, et al. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol. 2003; 149(6): 543-548.